新研股份(300159.SZ):2023年度預虧1.05億元-1.50億元
格隆匯1月29日丨新研股份(300159.SZ)公佈2023年度業績預吿,報吿期歸屬於上市公司股東的淨利潤虧損10,500萬元—15,000萬元,上年同期盈利7,656.70萬元;扣除非經常性損益後的淨利潤虧損12,000萬元—16,500萬元,上年同期盈利6,521.03萬元。
業績變動原因:1、報吿期內,由於航空航天行業外部市場環境變化因素的影響,客户產品升級換代導致年度排產計劃和訂單需求節奏有所調整,因此收入下降較多導致虧損。2、預計2023年度非經常性損益對公司股東淨利潤的影響金額約1,500萬元。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.